As both PANC-1 and Mia PaCa-2 cells already express very low or undetectable C/EBPδ levels, we turned to Capan-2 cells that, according to public gene expression datasets, show the highest CEBPD levels of all routinely used pancreatic cancer cell lines (Figure S4) [45,46]. This evidence concerns the gene CEBPD and pancreatic neoplasm.